ClinicalTrials.Veeva

Menu

Percutaneous Closure of Atrial Septal Defects in Children: Integration of 3D Echocardiography and Fluoroscopy Imaging. (CIA3DNAVIGATOR)

T

Toulouse University Hospital

Status

Completed

Conditions

Atrial Septal Defects

Treatments

Device: "Echonavigator" software

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02529111
RC31/14/7415

Details and patient eligibility

About

The interventional catheterization allows the percutaneous treatment of congenital heart diseases as the atrial septal defect (ASD). The examination is guided by the X-rays with stochastic side effects worrying at the child's. The software "Echonavigator" allows to merge the ultrasound image and fluoroscopic. This innovative software facilitates the procedures and reduce the irradiation time in some adult procedures.

The aim of this study was to validate the image fusion in children.

Full description

The software "Echonavigator" will be used after the introduction of the percutaneous closure of ASD prosthesis. The image fusion on fluoroscopy will then be applied and the bias between the generated ultrasound image and the X-ray view of the prosthesis will be measured. The center marker visible prosthesis ultrasound and fluoroscopy used as a reference marker.

Enrollment

20 patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Weight higher than or equal to 20 kg
  • Presence of an ostium secundum atrial septal defect diagnosed by transthoracic echocardiography and associated with a shunt from left to right evidenced by the significant dilation of the right cavities liable to a closure
  • The ASD should have an anatomy allowing percutaneous closure according to international recommendations

Exclusion criteria

  • Children with contraindication to transesophageal ultrasound according to international recommendations
  • ADS with minor shunt without indication of closure
  • Refusal to participate in the study expressed by parental authority

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

intervention
Experimental group
Description:
The "Echonavigator" software will be used on all patients. It will be used after the introduction of the percutaneous closure of ASD prosthesis. The image fusion on fluoroscopy will then be applied.
Treatment:
Device: "Echonavigator" software

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems